Cancer Research TCM Europe  2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, J.
Right arrow Articles by Hallahan, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, J.
Right arrow Articles by Hallahan, D. E.
[Cancer Research 66, 2320-2327, February 15, 2006]
© 2006 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

Protein Kinase B/Akt-Dependent Phosphorylation of Glycogen Synthase Kinase-3ß in Irradiated Vascular Endothelium

Jiahua Tan1, Ling Geng1, Eugenia M. Yazlovitskaya1,4 and Dennis E. Hallahan1,2,3,4

Departments of 1 Radiation Oncology, 2 Cancer Biology, and 3 Biomedical Engineering, 4 Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee

Requests for reprints: Eugenia M. Yazlovitskaya, Department of Radiation Oncology, The Vanderbilt Clinic, Vanderbilt University, 1301 22nd Avenue South, B-902 Nashville, TN 37232-5671. Phone: 615-343-9244; Fax: 615-343-3075; E-mail: eugenia.yazlovitskaya{at}vanderbilt.edu.

The vascular endothelium plays a critical role in the response of cancer to ionizing radiation. Activation of the phosphoinositide-3-kinase/Akt pathway is one initial signaling event in irradiated endothelial cells. Specifically, a low dose of ionizing radiation (3 Gy) induces phosphorylation of Akt at Ser473 in the vascular endothelium within minutes of irradiation. However, signaling events that are downstream of Akt have not been well defined. Here, we show that phosphorylation of the Akt downstream target glycogen synthase kinase-3ß (GSK-3ß) at Ser9 also occurred within minutes of exposure to ionizing radiation. In addition, ionizing radiation caused the dissociation of GSK-3ß from the cell membrane, consistent with the inactivation of GSK-3ß enzyme activity. Overexpression of the dominant negative mutant Akt attenuated GSK-3ß phosphorylation at Ser9 and enhanced radiation-induced apoptosis. X-irradiated endothelial cells formed capillaries in both in vitro and in vivo models, whereas overexpression of the dominant negative mutant Akt inhibited capillary tubule formation. Studies using GSK-3ß antagonists showed that GSK-3ß activity was required for apoptosis in endothelial cells treated simultaneously with Akt antagonists and radiation. In mouse vascular models, radiation-induced microvascular destruction in response to Akt antagonists also required GSK-3ß function. These data indicate that on exposure of vascular endothelium to ionizing radiation, activation of Akt signaling contributes to GSK-3ß inhibition, which in turn promotes endothelial cell survival and capillary formation. Thus, pharmacologic regulation of Akt/GSK-3ß signaling may present a new approach to the radiation response in the tumor microvasculature. (Cancer Res 2006; 66(4): 2320-7)




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
O. Ekshyyan, Y. Rong, X. Rong, K. M. Pattani, F. Abreo, G. Caldito, J. K. S. Chang, F. Ampil, J. Glass, and C.-A. O. Nathan
Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma
Mol. Cancer Ther., August 1, 2009; 8(8): 2255 - 2265.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Tu, D. Thotala, L. Geng, D. E. Hallahan, and C. D. Willey
Bone Marrow X Kinase-Mediated Signal Transduction in Irradiated Vascular Endothelium
Cancer Res., April 15, 2008; 68(8): 2861 - 2869.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Z. Li, F. Tan, and C. J. Thiele
Inactivation of glycogen synthase kinase-3 contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells
Mol. Cancer Ther., December 1, 2007; 6(12): 3113 - 3121.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. C. Spalding, R. Watson, M. E. Davis, A. C. Kim, T. S. Lawrence, and E. Ben-Josef
Inhibition of Protein Kinase C{beta} by Enzastaurin Enhances Radiation Cytotoxicity in Pancreatic Cancer
Clin. Cancer Res., November 15, 2007; 13(22): 6827 - 6833.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. C. Cuneo, T. Tu, L. Geng, A. Fu, D. E. Hallahan, and C. D. Willey
HIV Protease Inhibitors Enhance the Efficacy of Irradiation
Cancer Res., May 15, 2007; 67(10): 4886 - 4893.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.